Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial

Journal: Lancet HIV

Volume: 

Issue: 

Year of Publication: 2022

Affiliated Institutions: 

Abstract summary 

Authors & Co-authors: 

Study Outcome 

Source Link: Visit source

Statistics
Citations :  2
Authors :  0
Identifiers
Doi : 10.1016/S2352-3018(22)00044-3
SSN : 
Study Population
Male,Female
Mesh Terms
Other Terms
Study Design
Study Approach
Country of Study
Kenya
Publication Country